Literature DB >> 9425569

An image of the brain in patients with liver disease.

A H Lockwood1, K Weissenborn, R F Butterworth.   

Abstract

As imaging techniques have advanced from those that are based on tissue density and hence are strictly anatomical in nature, to include those based on physiologic and biochemical factors, the expectation has grown that imaging will be used to evaluate patients with diseases that are caused by disordered metabolism. In this review, recent advances in neuroimaging are discussed that have led to new insights into the pathophysiology of hepatic encephalopathy, a common condition that is caused by the failure of the liver to remove metabolic wastes from the blood.

Entities:  

Mesh:

Year:  1997        PMID: 9425569     DOI: 10.1097/00019052-199712000-00016

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  9 in total

1.  Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics.

Authors:  Alan H Lockwood; Karin Weissenborn; Martin Bokemeyer; U Tietge; Wolfgang Burchert
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

Review 2.  Functional imaging of the brain in patients with liver cirrhosis.

Authors:  Karin Weissenborn; Martin Bokemeyer; Björn Ahl; Daniela Fischer-Wasels; Kathrin Giewekemeyer; Jörg van den Hoff; Herbert Köstler; Georg Berding
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

4.  Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome.

Authors:  A M McKinney; B D Lohman; B Sarikaya; E Uhlmann; J Spanbauer; T Singewald; J R Brace
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-06       Impact factor: 3.825

Review 5.  Neuropsychological aspects of liver disease and its treatment.

Authors:  R E O'Carroll
Journal:  Neurochem Res       Date:  2007-10-24       Impact factor: 3.996

6.  Moderate grade hyperammonemia activates lactate dehydrogenase-4 and 6-phosphofructo-2-kinase to support increased lactate turnover in the brain slices.

Authors:  Aditi Mehrotra; Surendra Kumar Trigun
Journal:  Mol Cell Biochem       Date:  2013-05-24       Impact factor: 3.396

7.  Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study.

Authors:  Raffaele Nardone; Thomas Buratti; Antonio Oliviero; Andreas Lochmann; Frediano Tezzon
Journal:  J Neurol       Date:  2005-08-04       Impact factor: 6.682

Review 8.  Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology.

Authors:  Roger F Butterworth
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

Review 9.  Antibiotics and Liver Cirrhosis: What the Physicians Need to Know.

Authors:  Caterina Zoratti; Rita Moretti; Lisa Rebuzzi; Irma Valeria Albergati; Antonietta Di Somma; Giuliana Decorti; Stefano Di Bella; Lory Saveria Crocè; Mauro Giuffrè
Journal:  Antibiotics (Basel)       Date:  2021-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.